Resources
-
CGTP 2025 Scientific Program
Scientific Program: CGTP 2025
-
CGTP Summit 2025 Summary Infographic
Summary Infographic: CGTP Summit 2025
-
Advancing Genomic Medicine: Navigating Challenges in CMC Potency Assay Development Throughout the Product Life-Cycle
Speaker Presentation: CGTP Summit 2025
Nair Savita, Ramsey Phillip, Sangamo Therapeutics, Inc., 2025 -
Session I Introductory Slides from Co-chairs
Speaker Presentation: CGTP Summit 2025
Gianelli Francois, TreeFrog Therapeutics, Peters Elaine, 2025 -
Strategy for Potency Determination of Gene Therapy Products - Overview of the BioPhorum GT Potency Strategy Workstream
Speaker Presentation: CGTP Summit 2025
Borghese Fabian, UCB S.A., 2025 -
CGTP Summit 2025 Scientific Program
Scientific Program: CGTP Summit 2025
-
Look Up or Don’t Look Up? A Deep Dive into Bioassay Data Analysis
Speaker Presentation: Consultants' Network June 2025
Stetsenko Anton, BioQual Consulting LLC, 2025 -
Case Examples of CMC Surprises
Speaker Presentation: Consultants' Network June 2025
Sharokh Zahra, STC Biologics, 2025 -
Symposium on mRNA 2025 Summary Infographic
Summary Infographic: Symposium on mRNA 2025
-
Symposium on mRNA 2025 Scientific Program
Scientific Program: Symposium on mRNA 2025
-
Metaphorical mRNA: The Current & Future Shape(s) of the mRNA Therapeutics Industry
Speaker Presentation: Symposium on mRNA 2025
Welch Anna Rose, Advancing RNA, 2025 -
mRNA Vaccines an EU Regulator‘s Perspective
Speaker Presentation: Symposium on mRNA 2025
Schlick Petra, AGES - Austria, 2025 -
Quality by Design for
mRNA Products
Speaker Presentation: Symposium on mRNA 2025
O'Neill Julia, Direxa Consulting, 2025 -
Development of mRNA-LNP Manufacturing Process Platform
Speaker Presentation: Symposium on mRNA 2025
Luthra Sumit, Sanofi, 2025 -
Establishing Quality Benchmarks: Platform
Technology Approach to mRNA Product Quality
Speaker Presentation: Symposium on mRNA 2025
Kattel Sarita, US Pharmacopeia, 2025 -
Early Regulatory Considerations for RNA Therapies for Rare Diseases
Speaker Presentation: Symposium on mRNA 2025
Hagan Julie, Korro Bio, 2025 -
Analytical Comparability of mRNA Vaccines: Supporting the
Global Rollout of Comirnaty® and Streamlining the Strategy for
the mRNA Vaccine Pipeline
Speaker Presentation: Symposium on mRNA 2025
Eschmann Neil, Pfizer, Inc., 2025 -
A Trailblazing Digital
Approach Coupled with
PAT-Enabled Rapid
Manufacturing from MIT
and ReciBiopharm (Case
Study No. 01 xRNA)
Speaker Presentation: Symposium on mRNA 2025
Cowley Aaron, ReciBioPharm, 2025 -
A to Z of IVE: From Single Antigen to Multiplex Flow Cytometry and LC-MS/MS
Speaker Presentation: Symposium on mRNA 2025
Byrne Emilia, Pfizer, Inc., 2025 -
Streamlining Analytical Platform Procedures:
Addressing Early Phase Development Challenges
Speaker Presentation: Virtual Europe Discussion Group 2025
Eggink Mark, Byondis, 2025